These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 31091682)

  • 21. Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.
    Postler TS; Ghosh S
    Cell Metab; 2017 Jul; 26(1):110-130. PubMed ID: 28625867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms by Which the Gut Microbiota Influences Cytokine Production and Modulates Host Inflammatory Responses.
    Mendes V; Galvão I; Vieira AT
    J Interferon Cytokine Res; 2019 Jul; 39(7):393-409. PubMed ID: 31013453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nutrition-gut microbiome-physiology axis and allergic diseases.
    McKenzie C; Tan J; Macia L; Mackay CR
    Immunol Rev; 2017 Jul; 278(1):277-295. PubMed ID: 28658542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.
    Celiberto LS; Graef FA; Healey GR; Bosman ES; Jacobson K; Sly LM; Vallance BA
    Immunology; 2018 Sep; 155(1):36-52. PubMed ID: 29693729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of intestinal microbiota and metabolites in inflammatory bowel disease.
    Dong LN; Wang M; Guo J; Wang JP
    Chin Med J (Engl); 2019 Jul; 132(13):1610-1614. PubMed ID: 31090547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases.
    Yang W; Cong Y
    Cell Mol Immunol; 2021 Apr; 18(4):866-877. PubMed ID: 33707689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
    Sittipo P; Shim JW; Lee YK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease.
    Markandey M; Bajaj A; Ilott NE; Kedia S; Travis S; Powrie F; Ahuja V
    Gut Microbes; 2021; 13(1):1990827. PubMed ID: 34747326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.
    Leber A; Hontecillas R; Tubau-Juni N; Zoccoli-Rodriguez V; Abedi V; Bassaganya-Riera J
    Front Immunol; 2018; 9():363. PubMed ID: 29535731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut biofilm forming bacteria in inflammatory bowel disease.
    Srivastava A; Gupta J; Kumar S; Kumar A
    Microb Pathog; 2017 Nov; 112():5-14. PubMed ID: 28942174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology.
    Frosali S; Pagliari D; Gambassi G; Landolfi R; Pandolfi F; Cianci R
    J Immunol Res; 2015; 2015():489821. PubMed ID: 26090491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manipulation of epithelial integrity and mucosal immunity by host and microbiota-derived metabolites.
    Kayama H; Takeda K
    Eur J Immunol; 2020 Jul; 50(7):921-931. PubMed ID: 32511746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease.
    Harris KG; Chang EB
    Clin Sci (Lond); 2018 Sep; 132(18):2013-2028. PubMed ID: 30232239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comprehensive Review of the Triangular Relationship among Diet-Gut Microbiota-Inflammation.
    Randeni N; Bordiga M; Xu B
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of glycans in health and disease: Regulators of the interaction between gut microbiota and host immune system.
    Crouch LI; Rodrigues CS; Bakshani CR; Tavares-Gomes L; Gaifem J; Pinho SS
    Semin Immunol; 2024 May; 73():101891. PubMed ID: 39388764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
    Bruner SD; Jobin C
    Clin Pharmacol Ther; 2016 Jun; 99(6):585-7. PubMed ID: 26850686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPCR-Mediated Signaling of Metabolites.
    Husted AS; Trauelsen M; Rudenko O; Hjorth SA; Schwartz TW
    Cell Metab; 2017 Apr; 25(4):777-796. PubMed ID: 28380372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease.
    Pickard JM; Zeng MY; Caruso R; Núñez G
    Immunol Rev; 2017 Sep; 279(1):70-89. PubMed ID: 28856738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage interactions with fungi and bacteria in inflammatory bowel disease.
    Leonardi I; Li X; Iliev ID
    Curr Opin Gastroenterol; 2018 Nov; 34(6):392-397. PubMed ID: 30239343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.